United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UTHR | NBIX | CTLT | ||
| Company | United Therapeutic | Neurocrine Bioscienc | Catalent Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 236.59 | 137.47 | 55.88 | ||
| High | 237.53 | 138.63 | 56.11 | ||
| Low | 233.64 | 135.17 | 55.75 | ||
| Last | 233.85 | 135.99 | 55.92 | ||
| Change | -2.10 | -1.77 | +0.12 | ||
| % Change | -0.89% | -1.28% | +0.22% | ||
| Volume | 369,600 | 717,500 | 2,846,300 | ||
| 20-Day Average Volume | 491,470 | 765,780 | 1,688,135 | ||
| Previous Close | 235.95 | 137.76 | 55.80 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.48 | 136.46 | 56.30 | ||
| 20-Day Raw Stochastic | 62.10% | 39.41% | 28.09% | ||
| 20-Day Relative Strength | 49.91% | 49.27% | 50.06% | ||
| Weighted Alpha | +3.13 | +35.60 | +36.52 | ||
| Today's Opinion | 64% Buy | 48% Buy | 40% Buy | ||
| Previous Opinion | 80% Buy | 96% Buy | 40% Buy | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.71% since 04/19/24 | +3.02% since 04/19/24 | +0.79% since 04/19/24 | ||
| Low | 233.27 on 04/24/24 | 131.79 on 04/22/24 | 55.60 on 04/22/24 | ||
| High | 241.00 on 04/24/24 | 145.00 on 04/23/24 | 56.32 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -5.65% since 03/26/24 | -3.66% since 03/26/24 | -0.60% since 03/26/24 | ||
| Low | 221.53 on 04/01/24 | 130.13 on 04/19/24 | 55.42 on 04/19/24 | ||
| High | 249.68 on 03/27/24 | 145.00 on 04/23/24 | 57.20 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | +7.27% since 01/26/24 | -4.33% since 01/26/24 | +7.06% since 01/26/24 | ||
| Low | 208.62 on 02/08/24 | 128.00 on 02/07/24 | 51.54 on 01/31/24 | ||
| High | 250.89 on 03/26/24 | 148.37 on 03/21/24 | 60.20 on 02/05/24 | ||
| 6-Month | |||||
| %Chg | +4.21% since 10/26/23 | +26.01% since 10/26/23 | +42.40% since 10/26/23 | ||
| Low | 208.62 on 02/08/24 | 103.63 on 11/10/23 | 31.80 on 11/01/23 | ||
| High | 258.31 on 12/14/23 | 148.37 on 03/21/24 | 60.20 on 02/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,004,745 | 13,531,958 | 10,120,065 | ||
| Shares Outstanding, K | 47,059 | 99,507 | 180,974 | ||
| Annual Sales | 2,327,500,000 | 1,887,100,000 | 4,263,000,000 | ||
| Annual Net Income | 984,800,000 | 249,700,000 | -256,000,000 | ||
| Last Quarter Sales | 614,700,000 | 515,200,000 | 1,024,000,000 | ||
| Last Quarter Net Income | 217,100,000 | 147,700,000 | -206,000,000 | ||
| 60-Month Beta | 0.52 | 0.25 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.36 on 02/21/24 | 1.44 on 02/07/24 | -0.24 on 02/09/24 | ||
| Latest Earnings Date | 05/01/24 | 05/01/24 | 06/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.89 | 56.93 | 0.00 | ||